THE PETRIZZO GROUP, INC. for FATE THERAPEUTICS, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine for muscle regeneration and traumatic brain injury by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILLIP J BOND | — |
| TJ PETRIZZO | — |
Budget/Appropriations BUD
Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine for muscle regeneration and traumatic brain injury by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILLIP J BOND | — |
| TJ PETRIZZO | — |
Defense DEF
Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine for muscle regeneration and traumatic brain injury by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BARRENTINE GUAY | — |
| PHILLIP J BOND | — |
| TJ PETRIZZO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.